Institut National pour la Recherche Biomedicale

Ginkgo Bioworks and the Government of the Democratic Republic of the Congo Announce Plans to Develop and Implement New Biosecurity Capabilities in the Region

Retrieved on: 
Friday, April 14, 2023
INRB, DNA, DRC, Partnership, Biosecurity, Public, Institut National pour la Recherche Biomedicale, Concentric objects, Airport, Infection, Biomedical Research, Congo, Ministry, School, Public health, Data analysis, Democratic republic, Ginkgo Bioworks, Ministry of Public Health, Laboratory, Map, Weather, Hygiene, NYSE, Automation, Vaccine

The goal of the planned partnership is to support DRC's public health institutions as they work to address biosecurity challenges in the region.

Key Points: 
  • The goal of the planned partnership is to support DRC's public health institutions as they work to address biosecurity challenges in the region.
  • The collaboration aims to empower the DRC to form the foundation for a biosecurity and bioeconomy platform that serves the people of the DRC and the surrounding region.
  • "This partnership with the DRC is a testament to our shared commitment of enabling and advancing biosecurity initiatives for all," said Matt McKnight, General Manager, Biosecurity at Ginkgo Bioworks.
  • Effective pathogen monitoring and data sharing capabilities can empower government officials, community leaders, and other stakeholders to make informed public health decisions.

Ridgeback Biotherapeutics Responds to 13th Ebola Outbreak in Democratic Republic of Congo

Retrieved on: 
Wednesday, October 20, 2021
Health, Infectious Diseases, Other Health, General Health, Pharmaceutical, Biotechnology, Biomedical Advanced Research and Development Authority, Institut National pour la Recherche Biomedicale, Clinical trial, Severe acute respiratory syndrome coronavirus 2, Protalix BioTherapeutics, Democratic republic, Global Affairs Canada, NIAID, View, Death, Assistant, COVID-19, Institut national de recherche et de sécurité, Pharmacist, Antibody, PCR, VRC, Diagnosis, Merck, Contract, Collection, Senior, Data collection, Office of the Assistant Secretary for Preparedness and Response, Infection, Department, LP, United States Department of Health and Human Services, Ministry, CEO, VIR, Ansuvimab, EVD, Disease, Patient, Survival, DRC, Biodefense, Merck & Co., Food, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Ministry of Health and Social Welfare, Liberia, Vaccine, Pharmaceutical industry

Ridgeback Biotherapeutics (Ridgeback Bio), a biotechnology company experienced in antiviral drug development including medicines to treat SARS-Cov-2 and Ebola, announces deployment of the Ridgeback Ebola Rapid Response team to the Democratic Republic of the Congo (DRC).

Key Points: 
  • Ridgeback Biotherapeutics (Ridgeback Bio), a biotechnology company experienced in antiviral drug development including medicines to treat SARS-Cov-2 and Ebola, announces deployment of the Ridgeback Ebola Rapid Response team to the Democratic Republic of the Congo (DRC).
  • Ridgeback Bio is supporting a team of clinicians and pharmacists specialized in the treatment of Ebola Virus Disease (EVD) patients.
  • In order to achieve this, we have established the Ridgeback Ebola Rapid Response team which will work with our partners at the Institut National de Recherche in the Democratic Republic of the Congo.
  • Ridgeback Biotherapeutics markets EbangaTM for the treatment of Ebola and has a late-stage development pipeline which includes molnupiravir for the treatment of COVID-19.

Gut flora composition and function may impact susceptibility to konzo, a neurological disease caused by world staple crop cassava

Retrieved on: 
Monday, September 13, 2021
Desire, Konzo, Starch, Neurology, Oregon, Oregon Health & Science University, Nature Communications, Center, Â, Lists of diseases, Gene, Research, Democratic republic, Genetic distance, Risk, Disease, Hospital, DNA, Enzyme, Environment, FANA, Sugar, Diet, GLOBE, Sibling, Institut National pour la Recherche Biomedicale, Prevalence, Paralysis, Dietary supplement, Pharmaceutical industry

Cassava is a food security crop for over half a billion people in the developing world.

Key Points: 
  • Cassava is a food security crop for over half a billion people in the developing world.
  • It occurs after consuming poorly processed cassava a manioc root and essential crop for DRC and other low-income nations.
  • The exact biological mechanisms underlying konzo disease susceptibility and severity remained poorly understood until now.
  • This is the first study to shed light on the gut microbiome of populations that rely on toxic cassava as their primary food source.